Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that adjuvant metformin use in breast cancer patients with
overweight or pre-diabetes mellitus (DM) may improve their body condition including weight
loss.
In this study, the investigators aim to test the efficacy and safety of adjuvant metformin
for operable breast cancer patients with overweight or pre-DM.